ArticleCancer chemotherapy and pharmacology2021

Population pharmacokinetics of ATR inhibitor berzosertib in phase I studies for different cancer types.

Nadia Terranova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.